Bharat Biotech’s rotavirus vaccine gets WHO pre-qualification

By: |
Hyderabad | Published: January 25, 2018 6:07:24 AM

Bharat Biotech said the World Health Organization (WHO), Geneva, has granted pre-qualification to the world’s first rotavirus vaccine, Rotavac.

Bharat Biotech, rotavirus vaccine, who, who pre-qualification, World Health OrganizationBharat Biotech said the World Health Organization (WHO), Geneva, has granted pre-qualification to the world’s first rotavirus vaccine, Rotavac. (Image: Reuters)

Bharat Biotech said the World Health Organization (WHO), Geneva, has granted pre-qualification to the world’s first rotavirus vaccine, Rotavac. This vaccine helps prevent infant deaths and hospitalisation due to rotavirus diarrhoea, and is one of the first novel vaccines to be developed completely in India. A WHO pre-qualification is necessary for the UN agencies and GAVI (Global Alliance for Vaccine and Immunisation) in order to purchase the vaccine in partnership with developing countries and help accelerate availability of the drug to other developing countries.

“We are the first rotavirus vaccine manufacturer from the developing world and India to be WHO prequalified. The true impact of vaccines can be seen when vaccinations are carried out in affected populations. The government of India has given a big boost by making rotavac available to millions in India already,” CMD Krishna Ella said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Yes Bank launches overdraft facility on FDs
2Post-Covid retail loan losses may treble, hitting fintech lenders: CreditVidya
3Challenging Times: Capgemini’s Delaporte to be Wipro’s new CEO